Fluocinonide and Fexofenadine hydrochloride drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Fluocinonide (fluocinonide) and Fexofenadine hydrochloride (fexofenadine hydrochloride). Common drug interactions include injury among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Fluocinonide and Fexofenadine hydrochloride. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Fluocinonide?

Fluocinonide has active ingredients of fluocinonide. It is often used in eczema. eHealthMe is studying from 6,385 Fluocinonide users. Check the latest studies of Fluocinonide.

What is Fexofenadine hydrochloride?

Fexofenadine hydrochloride has active ingredients of fexofenadine hydrochloride. It is often used in allergies. eHealthMe is studying from 6,908 Fexofenadine hydrochloride users. Check the latest studies of Fexofenadine hydrochloride.

On Jul, 13, 2026

21 people who take Fluocinonide and Fexofenadine hydrochloride together, and have interactions are studied.

Fluocinonide and Fexofenadine hydrochloride drug interactions.

What are the common drug interactions of Fluocinonide and Fexofenadine Hydrochloride, by gender? *:

female:

Injury
Pulmonary embolism (blockage of the main artery of the lung)
Anxiety
Chronic kidney disease
Flushing (the warm, red condition of human skin)
Nephrogenic anaemia (anaemia due to kidney disease)
Respiratory tract infection
Sinusitis (inflammation of sinus)
Appetite disorder (abnormal eating habits)
Arthralgia (joint pain)

male:

Pneumonia
C-reactive protein increased
Blood pressure increased
Body height decreased
Contusion (a type of hematoma of tissue in which capillaries)
Decreased appetite
Encephalopathy (functioning of the brain is affected by some agent or condition)
Haemorrhage (bleeding)
Ill-defined disorder
Lower respiratory tract infection

What are the common drug interactions of Fluocinonide and Fexofenadine Hydrochloride, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Injury
Pulmonary embolism (blockage of the main artery of the lung)
C-reactive protein increased
Liver disorder (liver diseases)
Paraspinal abscess
Flushing (the warm, red condition of human skin)
Respiratory tract infection
Sinusitis (inflammation of sinus)
Arthralgia (joint pain)
Decreased appetite

50-59:

Injection site erythema (redness at injection site)
Injection site irritation
Injection site nodule (small swelling or aggregation of cells in the body, esp. an abnormal one at injection site)
Rash macular (small, flat red spots)

60+:

Appetite disorder (abnormal eating habits)
Dizziness
Rash
Syncope (loss of consciousness with an inability to maintain postural tone)
Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)
Dry skin
Dyspnoea (difficult or laboured respiration)
Encephalopathy (functioning of the brain is affected by some agent or condition)
Fatigue (feeling of tiredness)
Muscular weakness (muscle weakness)

What are the existing conditions these people have? *

Joint Pain: 5 people, 23.81%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 4 people, 19.05%
Asthma: 4 people, 19.05%
Stomatitis (inflammation of mucous membrane of mouth): 3 people, 14.29%
Rashes (redness): 3 people, 14.29%
Nausea (feeling of having an urge to vomit): 3 people, 14.29%
Headache (pain in head): 3 people, 14.29%
Gastritis (inflammation of stomach): 3 people, 14.29%
Dry Skin: 3 people, 14.29%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 3 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Fluocinonide and Fexofenadine hydrochloride?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously